• 1 January 1985
    • journal article
    • research article
    • Vol. 232  (3) , 831-837
Abstract
Zopiclone and CGS 9896 [2-(4-chlorophenyl)-2,5-dihydro-3H-pyrazolo[4,3-c]quinolin-3-one] are 2 nonbenzodiazepine compounds which were shown to displace benzodiazepines from their binding sites. The behavioral effects of these 2 compounds in rats were compared with those of chlordiazepoxide. The 3 drugs produced dose-related increases in punished drinking as did pentobarbital and meprobamate but not PK 9084, which acts at benzodiazepine binding sites, or buspirone. Rates of lever pressing suppressed by punishment were increased by chlordiazepoxide and zopiclone. CGS 9896 exerted a similar although less marked effect. Lever pressing maintained by a differential reinforcement of low rate 18 s schedule of milk presentation was increased by low doses of chlordiazepoxide and zopiclone and decreased by higher doses leading to dose-related reductions in numbers of reinforcers obtained. CGS 9896 reduced the number of reinforcers without affecting the rate of responding. In rats trained to discriminate a dose of chlordiazepoxide from saline, chlordiazepoxide, zopiclone, pentobarbital and meprobamate produced chlordiazepoxide-appropriate responding. CGS 9896 produced chlordiazepoxide-appropriate responding at a wide range of doses although the stimulus properties of this compound appeared to be weaker than those of the other active drugs. Chlordiazepoxide and zopiclone produced dose-related increases in food intake in food-deprived rats. CGS 9896 had similar effects at low doses but its effects were less consistent at higher doses. Zopiclone has a behavioral profile very similar to that of chlordiazepoxide. Although many of the effects of CGS 9896 were similar to those of chlordiazepoxide, a number of differences were also observed.